British Business - July 24
July 24 (Reuters) -The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
The Times
- Britain's biggest student landlord Unite Group UTG.L is asking shareholders for an extra 450 million pounds ($579.96 million) to buy and build more halls of accommodation.
- Touchlight, a privately owned British biotechnology company backed by celebrity and wealthy investors has struck a DNA manufacturing licence agreement with GSK GSK.L.
The Guardian
- Britain's King Charles is set for a huge 45 million pound pay rise with an increase of more than 50% in his official annual income.
- The UK's NHS's finances are so dire that the whole health service may break unless it receives a massive cash injection, Whitehall's spending watchdog has warned.
The Telegraph
- World Aid Convoy, an aid charity in the UK, is under investigation by the Charity Commission over its alleged links to a pro-Hamas news agency.
- Prince Williams of Wales has chosen not to reveal how much tax he pays on the private income he receives from his vast property portfolio, marking a notable change in approach from when his father was heir to the throne.
Sky News
- Wegovy, a weight-loss jab, has been approved by the UK's medicines regulator for use in preventing heart attacks and strokes in overweight or obese adults.
- British astronaut Tim Peake has said the Boeing test pilots stuck on the International Space Station (ISS) are in no danger, despite uncertainty over how or when they will return to Earth.
The Independent
- Britain's Prime Minister Keir Starmer has suspended seven Labour MPs after they voted, against the government, to scrap the two-child benefit cap.
($1 = 0.7759 pounds)
(Compiled by Bengaluru newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
